Dr Reddy's Laboratories launches 'Redituxa'

Hyderabad, May 1: Dr Reddy's Laboratories has launched Redituxä, a monoclonal antibody used in the treatment of Non-Hodgkin's Lymphoma.

The launch, participated by more than 100 oncologists, was followed by a technical session on the development of the drug.

Dr Reddy's Laboratories chairperson Dr Anji Reddy said in the technical session that the pharmaceutical company was always committed to creating value by applying science to help people to lead a healthier life. The launch of Redituxä was yet another example towards this commitment added Dr Anji Reddy.

UNI